A detailed history of Stifel Financial Corp transactions in Renalytix PLC stock. As of the latest transaction made, Stifel Financial Corp holds 561,000 shares of RNLX stock, worth $84,150. This represents 0.0% of its overall portfolio holdings.

Number of Shares
561,000
Previous 558,400 0.47%
Holding current value
$84,150
Previous $480,000 73.13%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.23 - $0.93 $598 - $2,418
2,600 Added 0.47%
561,000 $129,000
Q1 2024

May 13, 2024

BUY
$0.26 - $1.47 $145,184 - $820,848
558,400 New
558,400 $480,000

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.